Clinical pathway of COVID-19 patients in primary health care in 30 European countries : Eurodata study
BACKGROUND: Most COVID-19 patients were treated in primary health care (PHC) in Europe.
OBJECTIVES: To demonstrate the scope of PHC workflow during the COVID-19 pandemic emphasising similarities and differences of patient's clinical pathways in Europe.
METHODS: Descriptive, cross-sectional study with data acquired through a semi-structured questionnaire in PHC in 30 European countries, created ad hoc and agreed upon among all researchers who participated in the study. GPs from each country answered the approved questionnaire. Main variable: PHC COVID-19 acute clinical pathway. All variables were collected from each country as of September 2020.
RESULTS: COVID-19 clinics in PHC facilities were organised in 8/30. Case detection and testing were performed in PHC in 27/30 countries. RT-PCR and lateral flow tests were performed in PHC in 23/30, free of charge with a medical prescription. Contact tracing was performed mainly by public health authorities. Mandatory isolation ranged from 5 to 14 days. Sick leave certification was given exclusively by GPs in 21/30 countries. Patient hotels or other resources to isolate patients were available in 12/30. Follow-up to monitor the symptoms and/or new complementary tests was made mainly by phone call (27/30). Chest X-ray and phlebotomy were performed in PHC in 18/30 and 23/30 countries, respectively. Oxygen and low-molecular-weight heparin were available in PHC (21/30).
CONCLUSION: In Europe PHC participated in many steps to diagnose, treat and monitor COVID-19 patients. Differences among countries might be addressed at European level for the management of future pandemics.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
The European journal of general practice - 29(2023), 2 vom: 21. Dez., Seite 2182879 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 08.06.2023 Date Revised 08.07.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/13814788.2023.2182879 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354485792 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354485792 | ||
| 003 | DE-627 | ||
| 005 | 20231226062326.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/13814788.2023.2182879 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1181.xml |
| 035 | |a (DE-627)NLM354485792 | ||
| 035 | |a (NLM)36943232 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ares-Blanco, Sara |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical pathway of COVID-19 patients in primary health care in 30 European countries |b Eurodata study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.06.2023 | ||
| 500 | |a Date Revised 08.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Most COVID-19 patients were treated in primary health care (PHC) in Europe | ||
| 520 | |a OBJECTIVES: To demonstrate the scope of PHC workflow during the COVID-19 pandemic emphasising similarities and differences of patient's clinical pathways in Europe | ||
| 520 | |a METHODS: Descriptive, cross-sectional study with data acquired through a semi-structured questionnaire in PHC in 30 European countries, created ad hoc and agreed upon among all researchers who participated in the study. GPs from each country answered the approved questionnaire. Main variable: PHC COVID-19 acute clinical pathway. All variables were collected from each country as of September 2020 | ||
| 520 | |a RESULTS: COVID-19 clinics in PHC facilities were organised in 8/30. Case detection and testing were performed in PHC in 27/30 countries. RT-PCR and lateral flow tests were performed in PHC in 23/30, free of charge with a medical prescription. Contact tracing was performed mainly by public health authorities. Mandatory isolation ranged from 5 to 14 days. Sick leave certification was given exclusively by GPs in 21/30 countries. Patient hotels or other resources to isolate patients were available in 12/30. Follow-up to monitor the symptoms and/or new complementary tests was made mainly by phone call (27/30). Chest X-ray and phlebotomy were performed in PHC in 18/30 and 23/30 countries, respectively. Oxygen and low-molecular-weight heparin were available in PHC (21/30) | ||
| 520 | |a CONCLUSION: In Europe PHC participated in many steps to diagnose, treat and monitor COVID-19 patients. Differences among countries might be addressed at European level for the management of future pandemics | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Europe | |
| 650 | 4 | |a patient care management | |
| 650 | 4 | |a policy | |
| 650 | 4 | |a primary health care | |
| 650 | 4 | |a standard of care | |
| 700 | 1 | |a Guisado-Clavero, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a Ramos Del Rio, Lourdes |e verfasserin |4 aut | |
| 700 | 1 | |a Gefaell Larrondo, Ileana |e verfasserin |4 aut | |
| 700 | 1 | |a Fitzgerald, Louise |e verfasserin |4 aut | |
| 700 | 1 | |a Adler, Limor |e verfasserin |4 aut | |
| 700 | 1 | |a Assenova, Radost |e verfasserin |4 aut | |
| 700 | 1 | |a Bakola, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Bayen, Sabine |e verfasserin |4 aut | |
| 700 | 1 | |a Brutskaya-Stempkovskaya, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Busneag, Iliana-Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Domeyer, Philippe-Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Gjorgjievski, Dragan |e verfasserin |4 aut | |
| 700 | 1 | |a Hoffmann, Kathryn |e verfasserin |4 aut | |
| 700 | 1 | |a Ільков, Оксана |e verfasserin |4 aut | |
| 700 | 1 | |a Trifon Karathanos, Vasilis |e verfasserin |4 aut | |
| 700 | 1 | |a Kirkovski, Aleksandar |e verfasserin |4 aut | |
| 700 | 1 | |a Knežević, Snežana |e verfasserin |4 aut | |
| 700 | 1 | |a Çimen Korkmaz, Büsra |e verfasserin |4 aut | |
| 700 | 1 | |a Heleno, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Nessler, Katarzyna |e verfasserin |4 aut | |
| 700 | 1 | |a Murauskienė, Liubovė |e verfasserin |4 aut | |
| 700 | 1 | |a Neves, Ana Luisa |e verfasserin |4 aut | |
| 700 | 1 | |a Parodi López, Naldy |e verfasserin |4 aut | |
| 700 | 1 | |a Perjés, Ábel |e verfasserin |4 aut | |
| 700 | 1 | |a Petek, Davorina |e verfasserin |4 aut | |
| 700 | 1 | |a Petrazzuoli, Ferdinando |e verfasserin |4 aut | |
| 700 | 1 | |a Petricek, Goranka |e verfasserin |4 aut | |
| 700 | 1 | |a Seifert, Bohumil |e verfasserin |4 aut | |
| 700 | 1 | |a Serafini, Alice |e verfasserin |4 aut | |
| 700 | 1 | |a Sentker, Theresa |e verfasserin |4 aut | |
| 700 | 1 | |a Tiili, Paula |e verfasserin |4 aut | |
| 700 | 1 | |a Torzsa, Péter |e verfasserin |4 aut | |
| 700 | 1 | |a Vaes, Bert |e verfasserin |4 aut | |
| 700 | 1 | |a van Pottebergh, Gijs |e verfasserin |4 aut | |
| 700 | 1 | |a Vinker, Shlomo |e verfasserin |4 aut | |
| 700 | 1 | |a Astier-Peña, María Pilar |e verfasserin |4 aut | |
| 700 | 1 | |a Gómez-Bravo, Raquel |e verfasserin |4 aut | |
| 700 | 1 | |a Lingner, Heidrun |e verfasserin |4 aut | |
| 700 | 0 | |a Clinical investigators† |e verfasserin |4 aut | |
| 700 | 0 | |a Clinical investigators: |e verfasserin |4 aut | |
| 700 | 1 | |a Divjak, Asja Ćosić |e investigator |4 oth | |
| 700 | 1 | |a Peña, Maryher Delphin |e investigator |4 oth | |
| 700 | 1 | |a Gómez-Johansson, Mila |e investigator |4 oth | |
| 700 | 1 | |a Hanževački, Miroslav |e investigator |4 oth | |
| 700 | 1 | |a Ivanna, Shushman |e investigator |4 oth | |
| 700 | 1 | |a Jandrić-Kočić, Marijana |e investigator |4 oth | |
| 700 | 1 | |a Kostić, Milena |e investigator |4 oth | |
| 700 | 1 | |a Krztoń-Królewiecka, Anna |e investigator |4 oth | |
| 700 | 1 | |a Sattler, Martin |e investigator |4 oth | |
| 700 | 1 | |a Saurek-Aleksandrovska, Natalija |e investigator |4 oth | |
| 700 | 1 | |a Yilmaz, Canan Tuz |e investigator |4 oth | |
| 700 | 1 | |a Valtonen, Kirsi |e investigator |4 oth | |
| 700 | 1 | |a Vasyl, Kaliy |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The European journal of general practice |d 1998 |g 29(2023), 2 vom: 21. Dez., Seite 2182879 |w (DE-627)NLM094551847 |x 1751-1402 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2023 |g number:2 |g day:21 |g month:12 |g pages:2182879 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/13814788.2023.2182879 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2023 |e 2 |b 21 |c 12 |h 2182879 | ||